263 related articles for article (PubMed ID: 27991847)
1. Different Vancomycin-Intermediate Staphylococcus aureus Phenotypes Selected from the Same ST100-hVISA Parental Strain.
Di Gregorio S; Fernandez S; Cuirolo A; Verlaine O; Amoroso A; Mengin-Lecreulx D; Famiglietti A; Joris B; Mollerach M
Microb Drug Resist; 2017 Jan; 23(1):44-50. PubMed ID: 27991847
[TBL] [Abstract][Full Text] [Related]
2. Increase in IS256 transposition in invasive vancomycin heteroresistant Staphylococcus aureus isolate belonging to ST100 and its derived VISA mutants.
Di Gregorio S; Fernandez S; Perazzi B; Bello N; Famiglietti A; Mollerach M
Infect Genet Evol; 2016 Sep; 43():197-202. PubMed ID: 27154328
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3.
Matsuo M; Cui L; Kim J; Hiramatsu K
Antimicrob Agents Chemother; 2013 Dec; 57(12):5843-53. PubMed ID: 24018261
[TBL] [Abstract][Full Text] [Related]
4. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
Katayama Y; Sekine M; Hishinuma T; Aiba Y; Hiramatsu K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3730-42. PubMed ID: 27067329
[TBL] [Abstract][Full Text] [Related]
5. A mutation of RNA polymerase β' subunit (RpoC) converts heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) into "slow VISA".
Matsuo M; Hishinuma T; Katayama Y; Hiramatsu K
Antimicrob Agents Chemother; 2015 Jul; 59(7):4215-25. PubMed ID: 25941225
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China.
Shen P; Zhou K; Wang Y; Song J; Liu Y; Zhou Y; Xiao Y
J Antimicrob Chemother; 2019 Sep; 74(9):2537-2543. PubMed ID: 31203362
[TBL] [Abstract][Full Text] [Related]
7. Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains.
Cafiso V; Bertuccio T; Spina D; Purrello S; Campanile F; Di Pietro C; Purrello M; Stefani S
PLoS One; 2012; 7(1):e29573. PubMed ID: 22253738
[TBL] [Abstract][Full Text] [Related]
8. Role of the
G C B; Sahukhal GS; Elasri MO
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307991
[No Abstract] [Full Text] [Related]
9. "Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3.
Saito M; Katayama Y; Hishinuma T; Iwamoto A; Aiba Y; Kuwahara-Arai K; Cui L; Matsuo M; Aritaka N; Hiramatsu K
Antimicrob Agents Chemother; 2014 Sep; 58(9):5024-35. PubMed ID: 24841271
[TBL] [Abstract][Full Text] [Related]
10. Comparative Genomics Identifies Novel Genetic Changes Associated with Oxacillin, Vancomycin and Daptomycin Susceptibility in ST100 Methicillin-Resistant
Di Gregorio S; Haim MS; Famiglietti ÁMR; Di Conza J; Mollerach M
Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830286
[TBL] [Abstract][Full Text] [Related]
11. VraR Binding to the Promoter Region of
Dai Y; Chang W; Zhao C; Peng J; Xu L; Lu H; Zhou S; Ma X
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289032
[TBL] [Abstract][Full Text] [Related]
12. Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3.
Matsuo M; Hishinuma T; Katayama Y; Cui L; Kapi M; Hiramatsu K
Antimicrob Agents Chemother; 2011 Sep; 55(9):4188-95. PubMed ID: 21746940
[TBL] [Abstract][Full Text] [Related]
13. Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing.
Chen CJ; Lin MH; Shu JC; Lu JJ
J Antimicrob Chemother; 2014 Feb; 69(2):349-54. PubMed ID: 24092658
[TBL] [Abstract][Full Text] [Related]
14. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
Howden BP; Johnson PD; Ward PB; Stinear TP; Davies JK
Antimicrob Agents Chemother; 2006 Sep; 50(9):3039-47. PubMed ID: 16940100
[TBL] [Abstract][Full Text] [Related]
15. Reduced vancomycin susceptibility and increased macrophage survival in Staphylococcus aureus strains sequentially isolated from a bacteraemic patient during a short course of antibiotic therapy.
Basco MDS; Kothari A; McKinzie PB; Revollo JR; Agnihothram S; Azevedo MP; Saccente M; Hart ME
J Med Microbiol; 2019 Jun; 68(6):848-859. PubMed ID: 31136294
[TBL] [Abstract][Full Text] [Related]
16. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
[TBL] [Abstract][Full Text] [Related]
17. Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
Katayama Y; Murakami-Kuroda H; Cui L; Hiramatsu K
Antimicrob Agents Chemother; 2009 Aug; 53(8):3190-6. PubMed ID: 19451283
[TBL] [Abstract][Full Text] [Related]
18. Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia.
Howden BP; Smith DJ; Mansell A; Johnson PD; Ward PB; Stinear TP; Davies JK
BMC Microbiol; 2008 Feb; 8():39. PubMed ID: 18304359
[TBL] [Abstract][Full Text] [Related]
19. Influence of IS
Kleinert F; Kallies R; Hort M; Zweynert A; Szekat C; Nagel M; Bierbaum G
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584147
[No Abstract] [Full Text] [Related]
20. Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India.
Bakthavatchalam YD; Babu P; Munusamy E; Dwarakanathan HT; Rupali P; Zervos M; John Victor P; Veeraraghavan B
PLoS One; 2019; 14(12):e0227009. PubMed ID: 31887179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
